Placeholder Banner

Dr. Moncef Slaoui “Excellent Choice” to Lead Operation Warp Speed

May 13, 2020
Media Contact
Author-Profile-Andrew-Segerman

Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement: 

“Dr. Moncef Slaoui is an excellent choice to lead the President’s Operation Warp Speed initiative. Over his long career, he has demonstrated a strong commitment to public health, innovation and a public-private partnership that are vital to building the collaborations we need to bring new therapeutics, diagnostics and vaccines to the American people. Dr. Slaoui has always stood for scientific excellence, and the biotechnology industry stands ready to work with him as we begin this new effort in the race to eradicate the pandemic.”

###

Discover More
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…
Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development.   The…
The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…